PHATHOM PHARMACEUTICALS, INC. (PHAT) Gross profit 2022–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual gross profit history from SEC filings — each fiscal year as reported.
$152.5MFY2025 · since FY2022: $0 → $152.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $152.5M | +222.6% |
| FY2024 | $47.3M | +9080.4% |
| FY2023 | $515,000 | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice